tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cutia Therapeutics Completes HK$240 Million Share Placement
Company AnnouncementsCutia Therapeutics Completes HK$240 Million Share Placement
1d ago
2487
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
PremiumCompany Announcements
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
9d ago
2487
Cutia Therapeutics Announces Board Changes
PremiumCompany Announcements
Cutia Therapeutics Announces Board Changes
9d ago
2487
Cutia Therapeutics Announces Board Composition and Committee Roles
PremiumCompany Announcements
Cutia Therapeutics Announces Board Composition and Committee Roles
9d ago
2487
Cutia Therapeutics Forms Nomination Committee to Enhance Governance
PremiumCompany Announcements
Cutia Therapeutics Forms Nomination Committee to Enhance Governance
9d ago
2487
Cutia Therapeutics Announces Key Administrative Changes and Office Relocation
PremiumCompany AnnouncementsCutia Therapeutics Announces Key Administrative Changes and Office Relocation
9d ago
2487
Cutia Therapeutics Advances in Dermatology with New Product Approvals
Premium
Company Announcements
Cutia Therapeutics Advances in Dermatology with New Product Approvals
9d ago
2487
Cutia Therapeutics Schedules Board Meeting for Interim Results Review
Premium
Company Announcements
Cutia Therapeutics Schedules Board Meeting for Interim Results Review
19d ago
2487
Cutia Therapeutics Gains Hong Kong Approval for Topical Finasteride Spray
PremiumCompany Announcements
Cutia Therapeutics Gains Hong Kong Approval for Topical Finasteride Spray
1M ago
2487
Cutia Therapeutics Gains Approval for Innovative Hair Loss Treatment in China
PremiumCompany Announcements
Cutia Therapeutics Gains Approval for Innovative Hair Loss Treatment in China
2M ago
2487
Cutia Therapeutics’ Phase III Trial Results for CU-30101 Accepted for Presentation
PremiumCompany Announcements
Cutia Therapeutics’ Phase III Trial Results for CU-30101 Accepted for Presentation
2M ago
2487
Cutia Therapeutics Successfully Passes All Resolutions at AGM
PremiumCompany Announcements
Cutia Therapeutics Successfully Passes All Resolutions at AGM
3M ago
2487
Cutia Therapeutics Schedules Annual General Meeting with Key Resolutions
PremiumCompany AnnouncementsCutia Therapeutics Schedules Annual General Meeting with Key Resolutions
5M ago
2487
Cutia Therapeutics Reports Strong Revenue Growth and Product Advancements in 2024
Premium
Company Announcements
Cutia Therapeutics Reports Strong Revenue Growth and Product Advancements in 2024
6M ago
2487
Cutia Therapeutics Schedules Board Meeting to Approve Annual Results
Premium
Company Announcements
Cutia Therapeutics Schedules Board Meeting to Approve Annual Results
6M ago
2487
Cutia Therapeutics Completes Promising Phase II Trials
PremiumCompany Announcements
Cutia Therapeutics Completes Promising Phase II Trials
8M ago
2487
Cutia Therapeutics Reports Promising Trial Results
PremiumCompany Announcements
Cutia Therapeutics Reports Promising Trial Results
9M ago
2487
Cutia Therapeutics Unveils Promising Phase III Trial Results
PremiumCompany Announcements
Cutia Therapeutics Unveils Promising Phase III Trial Results
9M ago
2487
Cutia Therapeutics CEO Increases Shareholding, Signals Confidence
PremiumCompany Announcements
Cutia Therapeutics CEO Increases Shareholding, Signals Confidence
10M ago
2487
Cutia Therapeutics Gains Approval for Acne Treatment
PremiumCompany AnnouncementsCutia Therapeutics Gains Approval for Acne Treatment
10M ago
2487
Cutia Therapeutics CEO Boosts Shareholding Confidence
Premium
Company Announcements
Cutia Therapeutics CEO Boosts Shareholding Confidence
10M ago
2487
Cutia Therapeutics Reports Impressive Revenue Growth
Premium
Company Announcements
Cutia Therapeutics Reports Impressive Revenue Growth
10M ago
2487

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >